Varex Imaging Corp key statistics and ratios
In fiscal 2025, Varex Imaging Corp had return on equity of -14.0%, an operating margin of -3.3%, debt equal to 78.3% of equity and a current ratio of 3.43. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2015Oct 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Oct 2020 | 2021Oct 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Oct 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 39.6% | 40.1% | 36.3% | 32.8% | 32.9% | 25.8% | 33.2% | 33.0% | 32.5% | 31.7% | 34.4% | 34.3% |
| Operating margin | 20.2% | 17.6% | 12.0% | 5.8% | 5.9% | −4.6% | 9.1% | 10.3% | 8.6% | 4.0% | −3.3% | 8.3% |
| Net margin | 12.7% | 11.0% | 7.4% | 3.6% | 2.0% | −7.8% | 2.1% | 3.5% | 5.3% | −6.0% | −8.3% | 2.6% |
| Free-cash-flow margin | 8.1% | 7.3% | 7.9% | 8.4% | 6.7% | −1.4% | 9.5% | −0.5% | 9.8% | 2.5% | 2.2% | −2.3% |
| Return on equity | 16.1% | 13.4% | 11.4% | 6.8% | 3.6% | −12.9% | 3.7% | 6.0% | 8.6% | −8.9% | −14.0% | 4.6% |
| Return on assets | — | 11.0% | 6.2% | 2.7% | 1.5% | −5.3% | 1.5% | 2.6% | 3.9% | −4.0% | −6.1% | 2.0% |
| Asset turnover | — | 1.00 | 0.84 | 0.76 | 0.77 | 0.68 | 0.72 | 0.74 | 0.73 | 0.66 | 0.73 | 0.78 |
| Current ratio | — | 4.63 | 3.26 | 3.01 | 2.50 | 3.25 | 3.33 | 3.52 | 4.04 | 3.32 | 3.43 | 3.38 |
| Debt to equity | 0.0% | 0.0% | 130.3% | 93.4% | 90.1% | 113.2% | 99.4% | 84.3% | 78.9% | 84.4% | 78.3% | 69.9% |
| Interest cover (operating income ÷ interest) | 106.3x | 57.4x | 6.8x | 2.1x | 2.2x | n/m | 1.8x | 2.2x | 2.6x | 1.1x | n/m | 1.9x |
| Effective tax rate | 36.7% | 34.3% | 30.5% | −10.1% | 26.5% | — | 37.4% | 30.8% | — | — | — | 18.8% |
| R&D as % of revenue | 8.0% | 8.6% | 9.6% | 10.7% | 10.0% | 10.7% | 8.8% | 9.0% | 9.5% | 10.7% | 10.8% | 10.6% |
| SG&A as % of revenue | 11.5% | 13.8% | 14.7% | 16.0% | 16.4% | 19.3% | 15.3% | 13.8% | 14.4% | 17.0% | 15.8% | 15.4% |
| Capital spending as % of revenue | 5.4% | 4.7% | 2.9% | 2.6% | 2.5% | 3.2% | 1.8% | 2.5% | 2.3% | 3.3% | 2.7% | 3.6% |
| Free cash flow ÷ net income | 63.6% | 66.1% | 106.6% | 236.0% | 336.1% | — | 445.4% | −14.5% | 185.0% | — | — | −91.4% |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Jan 2025 | 2025 Q2Apr 2025 | 2025 Q3Jul 2025 | 2025 Q4Oct 2025 | 2026 Q1Jan 2026 | 2026 Q2Apr 2026 | 2026 Q3Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 32.6% | 34.3% | 36.0% | 33.3% | 34.0% | 33.3% | 33.6% | 36.4% |
| Operating margin | 5.3% | 5.6% | 10.4% | −39.8% | 8.6% | 7.3% | 6.7% | 10.8% |
| Net margin | −24.8% | −0.2% | 3.2% | −43.9% | 5.3% | 1.1% | −3.8% | 7.5% |
| Free-cash-flow margin | 9.7% | 2.7% | 4.6% | 0.7% | 1.0% | −12.8% | −3.6% | 5.7% |
| Current ratio | 3.32 | 4.36 | 4.05 | 3.51 | 3.43 | 3.89 | 3.20 | 3.38 |
| Debt to equity | 83.8% | 105.0% | 103.2% | 80.7% | 77.8% | 77.1% | 73.3% | 69.9% |
| R&D as % of revenue | 10.6% | 11.8% | 10.3% | 10.5% | 10.6% | 10.4% | 10.3% | 11.1% |
| SG&A as % of revenue | 16.7% | 16.9% | 15.3% | 16.2% | 14.9% | 15.6% | 16.7% | 14.5% |
Financial health
- Short-term assets cover short-term liabilities $633m of assets due within a year against $187m of liabilities due within a year.
- Short-term assets cover long-term liabilities $633m short-term assets against $402m of longer-dated liabilities.
- More cash than debt $99m of cash against $347m of debt.
- Debt below 40% of shareholders' equity Debt is 70% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 88% to 70% over five years.
- A year's operating cash flow covers at least 20% of debt $11m of operating cash flow against $347m of debt.
- Operating profit covers interest at least five times over Operating income of $72m against $39m of interest.
Moat
Moderate moat
How hard Varex Imaging's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 13 / 20
Cash operating profit has been a median 10.4% of total assets over 9 years.
- Pricing power 11 / 20
Gross margin has been a median 32.7%, moving by 2.4 percentage points (standard deviation) across 10 years.
- Durability 1 / 20
Operating margin has been a median 6.9%; its worst year was -4.4%.
- Cash conversion 11 / 20
Free cash flow was positive in 9 of 10 years, at a median 4.7% of revenue.
- Discipline 16 / 20
The diluted share count rose 2.1% over five years; stock-based pay has been a median 1.7% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Inspire Medical Systems, Inc. statistics
- Alphatec Holdings, Inc. statistics
- Orthofix Medical Inc. statistics
- Irhythm Holdings, Inc. statistics
- Myriad Genetics Inc statistics
Head to head: INSP vs VREXATEC vs VREXOFIX vs VREX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies